DNAprint Genomics, Inc. (OTCBB:DNAG) announced an equity line of credit agreement with Dutchess Private Equities Fund, L.P. for gross proceeds of $10 million on March 30, 2007. The agreement is for a period of five years. Under each draw down the company may elect to issue an aggregate of either, 200% of the average daily volume for 10 trading days prior to the put date multiplied by the average of the three daily closing bid prices immediately preceding the put date, or $600,000 times the average of the lowest closing bid prices of its common stock during the specified pricing period. The investor shall purchase such dollar amounts at 93% of the lowest closing bid price of the shares during the five trading days after the notice. Athena Capital Partners, Inc. shall be the placement agent for the transaction and will receive a cash commission of 6% of the gross proceeds. On March 30, 2012, DNAprint Genomics, Inc. cancelled the transaction.